|1.||Tan, Ning-Hua: 2 articles (08/2015 - 02/2013)|
|2.||Zhao, Si-Meng: 2 articles (08/2015 - 03/2012)|
|3.||Zeng, Guang-Zhi: 2 articles (02/2013 - 03/2012)|
|4.||Leung, Ping-Chung: 1 article (08/2015)|
|5.||Fung, Kwok-Pui: 1 article (08/2015)|
|6.||Yue, Grace Gar-Lee: 1 article (08/2015)|
|7.||Leung, Hoi-Wing: 1 article (08/2015)|
|8.||Lau, Clara Bik-San: 1 article (08/2015)|
|9.||Wang, Zhe: 1 article (08/2015)|
|10.||Lee, Julia Kin-Ming: 1 article (08/2015)|
|2.||Breast Neoplasms (Breast Cancer)
08/01/2015 - "Hence, the present study aimed to investigate the effects of RA-V on cell adhesion, migration, invasion and matrix degradation, and its underlying mechanism in two human breast cancer cell lines MCF-7 (ER-positive) and MDA-MB-231 (ER-negative). "
08/01/2015 - "RA-V inhibits breast cancer cell migration, adhesion and ECM degradation in vitro, implying that RA-V is a potential anti-metastatic agent in breast cancer, and likely acts via PI3K/AKT and NF-κB signaling pathways in both ER-positive and ER-negative breast cancer cells."
02/15/2013 - "RA-V significantly inhibited the growth of human breast cancer MCF-7, MDA-MB-231 cells and murine breast cancer 4T1 cells. "
02/15/2013 - "In the present paper, we examined the effects of a natural cyclopeptide RA-V on human breast cancer cells and the underlying mechanisms. "
02/15/2013 - "Plant cyclopeptide RA-V kills human breast cancer cells by inducing mitochondria-mediated apoptosis through blocking PDK1-AKT interaction."
08/01/2015 - "Cyclopeptide RA-V has potent anti-tumor and anti-angiogenic activities, but its potential anti-metastatic activity is unknown. "
02/15/2013 - "The underlying anti-cancer mechanism of RA-V is related to the blockage of the interaction between PDK1 and AKT."
02/15/2013 - "Taken together, this study shows that RA-V, which can induce mitochondria-mediated apoptosis, exerts strong anti-tumor activity against human breast cancer. "
03/01/2012 - "Most exciting characteristic of cyclopeptides is a range of interesting bioactivities such as antibiotics gramicidin-S (2), vancomycin (3) and daptomycin (4), immunosuppressive cyclosporin-A (1) and astin-C (8), and anti-tumor aplidine (5), RA-V (6) and RA-VII (7). "
|2.||Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
|7.||Gramicidin (Gramicidin A)
|10.||Anti-Bacterial Agents (Antibiotics)